Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

allogeneic CD34-positive enriched peripheral blood stem cells

A preparation of allogeneic CD34+ selected peripheral blood stem cells (PBSCs) that can potentially be used for immune reconstitution purposes. Upon administration of the allogeneic CD34-positive enriched PBSCs after a hematopoietic cell transplantation (HCT), these cells may provide memory T-cell (Tm) recovery and potentially prevent viral infections. They potentially reduce the occurrence of graft-versus-host disease (GvHD) without increasing the risk of graft failure or poor graft function.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	allogeneic CD34+ PBSCs allogeneic CD34+-enriched peripheral blood stem cells donor-derived CD34-positive PBSCs

allogeneic CD34-positive enriched peripheral blood stem cells

Search NCI's Drug Dictionary